172 related articles for article (PubMed ID: 35568711)
1. m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer.
Lin JX; Lian NZ; Gao YX; Zheng QL; Yang YH; Ma YB; Xiu ZS; Qiu QZ; Wang HG; Zheng CH; Li P; Xie JW; Lu J; Chen QY; Cao LL; Lin M; Wang JB; Huang CM
Cell Death Dis; 2022 May; 13(5):463. PubMed ID: 35568711
[TBL] [Abstract][Full Text] [Related]
2. m
Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
4. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer.
Zhang Z; Wang X; Liu Y; Wu H; Zhu X; Ye C; Ren H; Chong W; Shang L; Li L
MedComm (2020); 2024 Feb; 5(2):e472. PubMed ID: 38292328
[TBL] [Abstract][Full Text] [Related]
5. LHPP promotes the intracellular reactive oxygen species accumulation and sensitivity of gastric cancer to cisplatin via JNK and p38 MAPK pathways.
Gao K; Yin N; Shen Z; Li Q; Chen P; Yang K
Histol Histopathol; 2023 Sep; 38(9):1055-1068. PubMed ID: 36546683
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
7. LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway.
Wang D; Li J; Li W
J Cancer; 2022; 13(14):3584-3592. PubMed ID: 36484014
[TBL] [Abstract][Full Text] [Related]
8. m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.
Xu W; Lai Y; Pan Y; Tan M; Ma Y; Sheng H; Wang J
Cell Death Dis; 2022 Aug; 13(8):715. PubMed ID: 35977935
[TBL] [Abstract][Full Text] [Related]
9.
Liao L; Duan D; Liu Y; Chen L
Cell Cycle; 2020 Jul; 19(14):1846-1854. PubMed ID: 32578511
[TBL] [Abstract][Full Text] [Related]
10. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
11. METTL14-mediated m
Fan HN; Chen ZY; Chen XY; Chen M; Yi YC; Zhu JS; Zhang J
Mol Cancer; 2022 Feb; 21(1):51. PubMed ID: 35164771
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
13. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
14. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
15. N
Luo F; Lin K
Exp Cell Res; 2022 Aug; 417(1):113176. PubMed ID: 35489385
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
17. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis.
Mi Y; Li Q; Liu B; Wang D; Liu Z; Wang T; Wang Y; Zang Y; Zhou Y; Wen Y; Ding Y
Gastric Cancer; 2023 Jan; 26(1):69-81. PubMed ID: 36114400
[TBL] [Abstract][Full Text] [Related]
19. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT.
Zheng J; Dai X; Chen H; Fang C; Chen J; Sun L
Biochem Biophys Res Commun; 2018 Sep; 503(2):1108-1114. PubMed ID: 29944886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
